All reports

KCE Reports 336C (2020) Immunoglobulins, which are produced from human plasma, are invaluable and costly medicines used to treat equally rare and sometimes very serious diseases. There is an ever increasing risk of shortage, both in Belgium and worldwide, which means that strategies must urgently be devised with a view to a better control of their supplies and optimisation of the way they are used.

KCE Reports 327C (2019) Immunoglobulins, which are produced from human plasma, are invaluable and costly medicines used to treat equally rare and sometimes very serious diseases. There is an ever increasing risk of shortage, both in Belgium and worldwide, which means that strategies must urgently be devised with a view to a better control of their supplies and optimisation of the way they are used.